2019
DOI: 10.1159/000503791
|View full text |Cite
|
Sign up to set email alerts
|

Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells

Abstract: The high expression of somatostatin receptor 2 (SST2) in growth hormone (GH)-secreting tumors represents the rationale for the clinical use of somatostatin analogs (SSAs) in acromegaly. Recently, the cytoskeletal protein Filamin A (FLNA) has emerged as key modulator of the responsiveness of GH-secreting pituitary tumors to SSAs by regulating SST2 signaling and expression. The aim of this study was to explore FLNA involvement in SST2 intracellular trafficking in tumor somatotrop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
16
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 41 publications
1
16
0
Order By: Relevance
“…A protective effect of FLNA from receptor degradation was also demonstrated for other receptors, including calcium-sensing receptor [125], calcitonin receptor [126], cystic fibrosis transmembrane conductance regulator [127], and the high-affinity IgG receptor FcgammaRI [128]. FLNA was required for efficient recycling of SST2 in GH-secreting PitNETs [129] and chemokine receptor CCR2 and β2-adrenergic receptor [130].…”
Section: Clinical Behavior Of Pituitary Tumors: the Role Of Scaffold Proteinsmentioning
confidence: 99%
See 1 more Smart Citation
“…A protective effect of FLNA from receptor degradation was also demonstrated for other receptors, including calcium-sensing receptor [125], calcitonin receptor [126], cystic fibrosis transmembrane conductance regulator [127], and the high-affinity IgG receptor FcgammaRI [128]. FLNA was required for efficient recycling of SST2 in GH-secreting PitNETs [129] and chemokine receptor CCR2 and β2-adrenergic receptor [130].…”
Section: Clinical Behavior Of Pituitary Tumors: the Role Of Scaffold Proteinsmentioning
confidence: 99%
“…In GH-secreting PitNET cells, FLNA was essential for SST2 internalization upon agonist incubation (Fig. 3) [129]. Despite FLNA being a binding partner of β-arrestin-2, FLNA knockdown did not prevent the formation of β-arrestin-2-SST2 complexes in GH3 cells but significantly impaired SST2 loading into cytosolic vesicles positive for the early endocytic and recycling markers, Rab5 and 4, respectively, and prevented SST2 recycling to the cell membrane [129].…”
Section: Clinical Behavior Of Pituitary Tumors: the Role Of Scaffold Proteinsmentioning
confidence: 99%
“…Rearrangement of actin cytoskeleton has been shown to play important roles in intracellular traffic (Gallop 2019 ) and various proteins have been shown to specifically regulate the transport of receptors like tubulin for AT 1 R and α 2B -adrenergic receptors (Duvernay et al 2011 ; Zhang et al 2013 ), filamin A for somatostatin receptor type 2 (Treppiedi et al 2019 ), and ERM proteins for tyrosine kinase receptors and viruses (Neisch and Fehon 2011 ). Our data reveal that beside the previously reported functions of fascin-1 (Adams 2004 ; Gallop 2019 ; Jayo and Parsons 2010 ), this actin bundling protein also mediates the traffic from plasma membrane to endo-lysosomal system.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, it has been proved that FLNA mediates octreotide-induced SSTR2 trafficking through endosomal proteins in acromegaly. Moreover, FLNA influences the number of available SSTR2 at the surface of the cell (73).…”
Section: Cytoskeleton Epithelial-mesenchymal Transition and Srl Resmentioning
confidence: 99%
“…Additionally, it has been proved that FLNA mediates octreotide-induced SSTR2 trafficking through endosomal proteins in acromegaly. Moreover, FLNA influences the number of available SSTR2 at the surface of the cell ( 73 ). For more detailed explanation of the cytoskeleton involvement in SRLs resistance, we recommend the review by Peverelli et al.…”
Section: Cytoskeleton Epithelial–mesenchymal Transition and Srl Resmentioning
confidence: 99%